Oncology The mesenchymal stem cell’s superpower: Hacking the TME What if we could reprogramme the TME itself? Cutting-edge research suggests that engineered mesenchymal stem cells (MSCs) could disrupt this shield.
Events Partner Content Patient-to-Patient Supply for Cell Immunotherapies Summit Achieving Standardization & Operational Excellence in Vein-to-Vein Supply